Skip to content
10-Q

Quarterly Report

U.S. STEM CELL, INC.

0001185185-21-000991

← back to feed
Filed
Jul 16, 2021 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding restated Q1 2021 · Jul 15, 2021 452.41M sh
Cash And Equivalents Q1 2021 · Mar 31, 2021 $444.11K
Cash And Equivalents Q1 2021 · Dec 31, 2020 $18.57K
Cash And Equivalents Q1 2021 · Mar 31, 2020 $30.79K
Current Liabilities Q1 2021 · Mar 31, 2021 $10.96M
Current Liabilities Q1 2021 · Dec 31, 2020 $10.85M
Total Liabilities Q1 2021 · Mar 31, 2021 $11.77M
Total Liabilities Q1 2021 · Dec 31, 2020 $11.67M
Current Assets Q1 2021 · Mar 31, 2021 $641.34K
Current Assets Q1 2021 · Dec 31, 2020 $88.15K
Total Assets Q1 2021 · Mar 31, 2021 $641.34K
Total Assets Q1 2021 · Dec 31, 2020 $88.15K
Operating Cash Flow Q1 2021 · Mar 31, 2020 −$94.66K
Sga Expense Q1 2021 · Mar 31, 2020 $537.54K
Net Income Q1 2021 · Mar 31, 2020 −$575.79K
Operating Income Q1 2021 · Mar 31, 2020 −$498.14K
Gross Profit Q1 2021 · Mar 31, 2020 $39.4K
Cost Of Revenue Q1 2021 · Mar 31, 2020 $18.1K
Revenue Q1 2021 · Mar 31, 2020 $57.49K